糖尿病肾脏疾病临床诊疗中国指南

标题: 糖尿病肾脏疾病临床诊疗中国指南
title: Chinese guidelines for diagnosis and treatment of diabetic kidney disease
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 广大肾科医师并供内分泌、心血管、肾移植等学科相应工作人员参考
Guide users: The guidelines can be used as a reference for nephrologists and corresponding staff in endocrine, cardiovascular, renal transplantation and other disciplines.
证据分级方法: Refer to the GRADE evidence quality rating and recommendation intensity system, as follows: A: evidence based on multiple RCT clinical trials or Meta analysis; B: evidence based on single RCT clinical trials or multiple non-randomized controlled trials; C: evidence based on non-randomized controlled trials or expert consensus; D: evidence based on case observation, case report.
Evidence grading method:
制定单位: 中华医学会肾脏病专业委员会
Formulating unit: Expert Group of Chinese Society of Nephrology
注册时间: 2021-02-18
Registration time:
注册编号: IPGRP-2021CN035
Registration number:
指南制订的目的: 国内外肾脏病专家均发表了有关DKD诊疗的共识与建议,为肾科医师防治DKD提供了重要的指导意见,但仍有待更新,特别是对于DM并发CKD患者这一特殊人群,如何精准地合理用药、规范诊疗、细化管理等仍有待完善,这也是我们临床工作中迫切需要解决的关键问题。另外,随着临床医学新技术的发展,有关DKD知识的不断更新,特别是新型药物的研发与利用,拓展了DKD临床诊疗的新策略。因此,更新和制定能对我国DKD临床诊治和预防进行全面指导的指南具有十分重要的临床意义。该指南制定的目的是进一步加强对DKD的认识,规范DKD诊疗体系,制定合理治疗原则,指导精准临床用药,延缓肾脏病进展,提高患者生活质量,并为广大肾科医师在临床工作中提供参考。
Purpose of the guideline: Experts at home and abroad have published consensus and recommendations on the diagnosis and treatment of DKD, which provides important guidance for nephrologists in the prevention and treatment of DKD, but it still needs to be updated, especially for this special group of patients with DM complicated with CKD, how to accurately and rationally use drugs, standardize diagnosis and treatment, detailed management and so on still need to be improved, which is also the key problem that urgently needs to be solved in our clinical work. In addition, with the development of new technology in clinical medicine, the continuous updating of knowledge about DKD, especially the research and development and utilization of new drugs, expand the new strategy of clinical diagnosis and treatment of DKD. Therefore, it is of great clinical significance to update and formulate guidelines that can provide comprehensive guidance for the clinical diagnosis, treatment and prevention of DKD in China.The purpose of this guideline is to further strengthen the understanding of DKD, standardize the DKD diagnosis and treatment system, formulate reasonable treatment principles, guide accurate clinical medication, delay the progression of kidney disease, improve the quality of life of patients, and provide reference for the majority of nephrologists in clinical work .